This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

New Resource Promises Information, Education And Inspiration When It Comes To Epilepsy In Canada

E-Action™ designed for the 300,000 living with the neurological disorder 1

OAKVILLE, ON, March 26, 2013 /CNW/ - Canadians with epilepsy, as well as their family, friends and caregivers, now have an exciting new information source and support network. E-Action™ - Taking Action Against Epilepsy strives to provide a caring and informative environment for those touched by the disorder.

E-Action™ includes a broad range of interactive education and information resources, including a magazine, a website, a mobile application (App), and a leader program that features 10 inspirational Canadians living well with epilepsy.

"Epilepsy associations across the country have been working tirelessly to help people with epilepsy live the best quality of life possible.  E-Action™ is a fantastic resource to help us do just that," said Gail Dempsey, President, Canadian Epilepsy Alliance (CEA).

"The program will go a long way in raising the profile of epilepsy, and ensuring that those living with the disorder can connect with the medical community, local epilepsy agencies, and their wider communities to obtain the best care and treatment available."

E-Action™ is an initiative of UCB Canada Inc., a global biopharmaceutical company committed to improving the lives of people with epilepsy, one of the most common neurological disorders, affecting approximately 1% of Canadians. 1

Despite the wide reach of this debilitating condition, there is a lack of awareness and knowledge about epilepsy, leading to social isolation, work barriers and relationship issues.

Awareness needs in Canada

In a survey released in 2011 2, just over half of the respondents said their independence is restricted, and 56% mentioned it as their number one challenge.  Stigma, discrimination and the lack of awareness about epilepsy among Canadians was mentioned as the number two challenge faced by 38% of respondents, along with the impact of the disorder on their social life.

E-Action™ tools and programming are designed to help those with epilepsy understand and take more control of their condition and educate others.
  • E-Action™ magazine provides educational and inspiring stories about Canadians living well with epilepsy. It shares insights from medical experts, updates from community leaders and other informative content.
  • enables visitors to locate education and support resources coast-to-coast, and provides up-to-date news.
  • E-Action™ Info is a mobile application (App) designed to help educate users. It includes important and interesting information about epilepsy and seizures, management tips, as well as seizure First Aid for caregivers and the public. Currently available on iPhones, iPads and the iPod Touch, it also features a unique teaching tool, the Brain Game, which explains different parts and functions of the brain.

"The general public and those living with epilepsy, and their caregivers, need a better understanding of epilepsy and its impact to optimize care and treatment, and ultimately reduce isolation and stigma. The E-Action App and all of the resources will go a long way to addressing these challenges," says Dr. Draga Jichici, a neurologist in Guelph, Ontario, who helped develop the E-Action™ Info App.

My Epilepsy Diary The App also links to My Epilepsy Diary Canada, which enables users to track their seizures, medicines, progress and overall well-being on their smartphone, tablet or computer. Users can then share this timely and relevant real word information with their doctors so they can optimize their epilepsy care. Users can also track and manage their therapies with reminders to be sent by text, email or local smart phone notification.

My Epilepsy Diary is available on all popular models of smartphones and tablets, and data is stored securely online. Patients know their records will be kept even if they switch phones or replace a lost phone, while their authorized physicians can access patient-reported outcomes immediately.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.24 0.00%
FB $117.81 0.00%
GOOG $701.43 0.00%
TSLA $211.53 0.00%
YHOO $36.94 0.00%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs